Ingigerdur S. Sverrisdottir
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2026
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance.
Journal: JAMA oncology
Published: May 29, 2025
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening study.
Journal: British journal of haematology
Published: September 19, 2024
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Journal: Annals of internal medicine
Published: May 20, 2024
Risk of infections in multiple myeloma. A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry.
Journal: Haematologica
Published: April 12, 2024
Respiratory syncytial virus and other vaccine-preventable infections in multiple myeloma. A population-based study on 8,672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry.
Journal: Haematologica
Published: January 26, 2024
Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients.
Journal: Transplantation and cellular therapy
Published: October 30, 2022
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
Journal: Blood cancer journal
Published: June 20, 2022
Fractures and survival in multiple myeloma: results from a population-based study.
Journal: Haematologica
Published: June 18, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026